Manulife (Manufacturers Life Insurance)
TEVA icon

Manulife (Manufacturers Life Insurance)’s Teva Pharmaceuticals TEVA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
415,097
+66,199
+19% +$2.2M 0.01% 752
2026
Q1 		$10.5M Sell
348,898
-155,079
-31% -$4.99M 0.01% 831
2025
Q4 		$15.7M Buy
503,977
+80,011
+19% +$1.97M 0.01% 709
2025
Q3 		$8.56M Sell
423,966
-8,601
-2% -$151K 0.01% 932
2025
Q2 		$7.25M Buy
432,567
+30,817
+8% +$497K 0.01% 996
2025
Q1 		$6.17M Sell
401,750
-111,578
-22% -$1.99M 0.01% 1069
2024
Q4 		$11.3M Buy
513,328
+80,926
+19% +$1.47M 0.01% 823
2024
Q3 		$7.79M Buy
432,402
+24,248
+6% +$424K 0.01% 1009
2024
Q2 		$6.63M Sell
408,154
-4,004
-1% -$61.7K 0.01% 1037
2024
Q1 		$5.82M Sell
412,158
-20,303
-5% -$256K 0.01% 1123
2023
Q4 		$4.51M Sell
432,461
-200
-0% -$1.87K ﹤0.01% 1208
2023
Q3 		$4.41M Sell
432,661
-40,035
-8% -$373K ﹤0.01% 1173
2023
Q2 		$3.56M Sell
472,696
-500
-0.1% -$4.05K ﹤0.01% 1227
2023
Q1 		$4.19M Buy
473,196
+18,400
+4% +$182K ﹤0.01% 1163
2022
Q4 		$4.15M Sell
454,796
-12,200
-3% -$106K ﹤0.01% 1153
2022
Q3 		$3.77M Sell
466,996
-5,400
-1% -$47.8K ﹤0.01% 1169
2022
Q2 		$3.55M Sell
472,396
-500
-0.1% -$4.36K ﹤0.01% 1244
2022
Q1 		$4.44M Sell
472,896
-120,800
-20% -$1.01M ﹤0.01% 1244
2021
Q4 		$4.75M Sell
593,696
-12,600
-2% -$114K ﹤0.01% 1283
2021
Q3 		$5.91M Buy
606,296
+180,500
+42% +$1.69M ﹤0.01% 1173
2021
Q2 		$4.21M Sell
425,796
-26,700
-6% -$283K ﹤0.01% 1357
2021
Q1 		$5.22M Sell
452,496
-19,300
-4% -$221K ﹤0.01% 1254
2020
Q4 		$4.55M Buy
471,796
+12,300
+3% +$118K ﹤0.01% 1251
2020
Q3 		$4.14M Sell
459,496
-60,020
-12% -$635K ﹤0.01% 1182
2020
Q2 		$6.33M Sell
519,516
-17,196
-3% -$194K 0.01% 994
2020
Q1 		$4.82M Sell
536,712
-16,400
-3% -$168K 0.01% 1033
2019
Q4 		$5.42M Sell
553,112
-17,600
-3% -$157K 0.01% 1157
2019
Q3 		$3.95M Buy
570,712
+11,494
+2% +$88.1K ﹤0.01% 1231
2019
Q2 		$5.16M Buy
559,218
+38,306
+7% +$462K 0.01% 1164
2019
Q1 		$8.17M Buy
520,912
+6,200
+1% +$109K 0.01% 975
2018
Q4 		$7.94M Buy
514,712
+146,300
+40% +$3M 0.01% 911
2018
Q3 		$7.93M Sell
368,412
-450
-0.1% -$10.4K 0.01% 1017
2018
Q2 		$8.97M Buy
368,862
+9,271
+3% +$189K 0.01% 947
2018
Q1 		$6.14M Buy
359,591
+472
+0.1% +$9.22K 0.01% 1148
2017
Q4 		$6.81M Sell
359,119
-3,126
-0.9% -$47K 0.01% 1072
2017
Q3 		$6.38M Sell
362,245
-52,773
-13% -$1.19M 0.01% 1049
2017
Q2 		$13.8M Sell
415,018
-16,985
-4% -$526K 0.02% 682
2017
Q1 		$13.9M Sell
432,003
-8,355
-2% -$285K 0.02% 670
2016
Q4 		$16M Buy
440,358
+362,368
+465% +$14.5M 0.02% 566
2016
Q3 		$3.59M Buy
77,990
+16,886
+28% +$881K 0.01% 1221
2016
Q2 		$3.07M Sell
61,104
-457
-0.7% -$24.3K ﹤0.01% 1239
2016
Q1 		$3.35M Sell
61,561
-69,473
-53% -$4.08M ﹤0.01% 1236
2015
Q4 		$8.6M Buy
131,034
+80,358
+159% +$4.97M 0.01% 748
2015
Q3 		$2.86M Sell
50,676
-12,287
-20% -$797K ﹤0.01% 1273
2015
Q2 		$3.72M Sell
62,963
-2,209
-3% -$136K ﹤0.01% 1200
2015
Q1 		$4.06M Buy
65,172
+6,906
+12% +$402K 0.01% 1138
2014
Q4 		$3.35M Buy
58,266
+1,535
+3% +$85.5K ﹤0.01% 1163
2014
Q3 		$3.05M Sell
56,731
-7,195
-11% -$381K ﹤0.01% 1210
2014
Q2 		$3.35M Sell
63,926
-12,402
-16% -$634K 0.01% 1197
2014
Q1 		$4.03M Buy
76,328
+140
+0.2% +$6.47K 0.01% 1109
2013
Q4 		$3.05M Hold
76,188
– – ﹤0.01% 1210
2013
Q3 		$2.88M Sell
76,188
-8,384
-10% -$327K ﹤0.01% 1192
2013
Q2 		$3.31M Buy
+84,572
New +$3.29M 0.01% 1064

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TEVA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Teva Pharmaceuticals (TEVA) stake by 19% in Q2 2026, buying an estimated $2.2M and bringing the position to 415,097 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #752.

Manulife (Manufacturers Life Insurance) first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $16M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 415,097 shares of Teva Pharmaceuticals worth $14.1M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 66,199 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.2M.
  • Teva Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #752 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Teva Pharmaceuticals position peaked at $16M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.